John R. Stringham

John R. Stringham, MD

Languages spoken: English

Academic Information

Departments Adjunct - Surgery

Board Certification

  • American Board of Surgery
  • American Board of Thoracic Surgery (Thoracic Surg)

Research Interests

  • General Thoracic Surgery
  • Robotic Thoracic Surgery
  • Chest Wall Reconstruction
  • Lung Transplantation
  • Thoracic Oncology
  • Surgical Clinical Outcomes
  • Esophageal and Upper GI Surgery
  • Airway Surgery

JOHN STRINGHAM, MD, is originally from Nashville, Tennessee. He earned his medical degree from Vanderbilt University School of Medicine. He completed a general surgery residency at the University of Colorado which included time working at the Trauma Research Center. He then completed a thoracic surgery fellowship at the University of Virginia in Charlottesville, VA. Dr. Stringham’s clinical interests include all aspects of benign and malignant pathology of the lung, mediastinum and esophagus. He has a specific interest in lung transplant surgery. He also has interest in disorders of the airway and chest wall including tumor resection and reconstruction. Research interests include technological innovations in thoracic surgery, and patient outcomes after thoracic surgery utilizing population-based data.

Education History

Fellowship University of Virginia Health System
 Fellow
Chief Resident University of Colorado School of Medicine
 Chief Resident
Residency University of Colorado School of Medicine
 Resident
Research Fellow University of Colorado School of Medicine, Trauma Research Center
 Research Fellow
Residency University of Colorado School of Medicine
 Resident
Internship University of Colorado School of Medicine
 Intern
Clerkship Vanderbilt University School of Medicine
 MD
Professional Medical Vanderbilt University School of Medicine
 MD
Clerkship Vanderbilt University School of Medicine
 MD
Undergraduate Vanderbilt University
 BS

Selected Publications

Journal Article

  1. Stokes SM, Massarweh NN, Stringham JR, Varghese TK Jr (2020). Impact of Multimodality Treatment Sequence on Survival in Stage IIB Non-Small Cell Lung Cancer. Ann Thorac Surg. (Read full article)
  2. Pannucci CJ, Fleming KI, Varghese TK Jr, Stringham J, Huang LC, Pickron TB, Prazak AM, Bertolaccini C, Momeni A (2020). Low anti-Factor Xa level predicts 90-day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis: A Pooled Analysis of Eight Clinical Trials. Ann Surg. (Read full article)
  3. Pannucci CJ, Fleming KI, Bertolaccini C, Moulton L, Stringham J, Barnett S, Lin J, Varghese TK Jr (2020). Fixed or Weight-Tiered Enoxaparin After Thoracic Surgery for Venous Thromboembolism Prevention. Ann Thorac Surg, 109(6), 1713-1721. (Read full article)
  4. Stokes SM, Massarweh NN, Stringham JR, Varghese TK Jr (2019). Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer. Ann Thorac Surg, 108(3), 837-844. (Read full article)
  5. Cahill BC, Raman S, Stringham JR, McKellar SH, Selzman CH, Liou TG (2018). Longer Life or More Life: Choose One Please. J Surg Res, 237, 126-128. (Read full article)
  6. Stokes SM, Wakeam E, Swords DS, Stringham JR, Varghese TK Jr (2018). Impact of insurance status on receipt of definitive surgical therapy and posttreatment outcomes in early stage lung cancer. Surgery, 164(6), 1287-1293. (Read full article)
  7. Nunns GR, Stringham JR, Gamboni F, Moore EE, Fragoso M, Stettler GR, Silliman CC, Banerjee A (2018). Trauma and hemorrhagic shock activate molecular association of 5-lipoxygenase and 5-lipoxygenase-Activating protein in lung tissue. J Surg Res, 229, 262-270. (Read full article)

News & Podcasts

Huntsman Cancer Institute News